Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease (2012)
- Authors:
- Autor USP: NUNES, ANDERSON DE SÁ - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Publisher: European Federation of Immunological Societies
- Publisher place: Glasgow
- Date published: 2012
- Conference titles: European Congress of Immunology (EFIS)
-
ABNT
CAMPOS, H. S. et al. Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. 2012, Anais.. Glasgow: European Federation of Immunological Societies, 2012. . Acesso em: 24 abr. 2024. -
APA
Campos, H. S., Souza, P. R., Nunes, A. de S., & Cardoso, C. R. B. (2012). Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. In . Glasgow: European Federation of Immunological Societies. -
NLM
Campos HS, Souza PR, Nunes A de S, Cardoso CRB. Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. 2012 ;[citado 2024 abr. 24 ] -
Vancouver
Campos HS, Souza PR, Nunes A de S, Cardoso CRB. Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. 2012 ;[citado 2024 abr. 24 ] - Mast cells and basophils: from malevolent design to coevolutionary arms race
- Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity
- The function and three-dimensional structure of a thromboxane A2/cysteinyl leukotriene-binding protein from the saliva of a mosquito vector of the malaria parasite
- Animal models for the two hypotheses of trali pathology
- The role of saliva in tick feeding
- Tick salivary kunitz-type inhibitors: targeting host hemostasis and immunity to mediate successful blood feeding
- Contribuições ao estudo da histoplasmose experimental murina
- Adenosine and adenosine-monophosphate present into the Phlebotomus papatasi saliva block dendritic cell function and ammeliorate collagen-induced arthritis
- The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity
- Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
